Central African Republic vs Gabon: Deaths from Alzheimer's
Central African Republic
202.14 deaths
in 2021
Gabon
199.44 deaths
in 2021
Central African Republic rank
139th
Gabon rank
140th
Deaths from Alzheimer's over time
- Central African Republic
- Gabon
How they compare
Central African Republic currently reports 202.14 deaths against 199.44 deaths in Gabon, a difference of 2.7 deaths.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Central African Republic ahead.
Central African Republic ranks 139th and Gabon ranks 140th of 194 countries.
Across the 3 decades both report, Central African Republic averaged higher in 2 and Gabon in 1.
Head to head by decade
| Decade | Central African Republic | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 168.3 deaths | 164.71 deaths | 3.59 deaths | Central African Republic |
| 2010s | 182.92 deaths | 217.73 deaths | 34.82 deaths | Gabon |
| 2020s | 212.39 deaths | 204.26 deaths | 8.13 deaths | Central African Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher deaths from alzheimer's, Central African Republic or Gabon?
- Central African Republic, at 202.14 deaths against 199.44 deaths in Gabon as of 2021.
- What is the difference in deaths from alzheimer's between Central African Republic and Gabon?
- 2.7 deaths, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Gabon?
- 22 years are reported by both, from 2000 to 2021.
- How do Central African Republic and Gabon rank globally for deaths from alzheimer's?
- Central African Republic ranks 139th and Gabon ranks 140th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Deaths from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes.